Pharmaceutical Executive January 20, 2025
Panel participants share an optimistic outlook for integrating new innovations, tacking community-level challenges, and more.
J.P. Morgan held its 43rd Annual Healthcare Conference, January 13-16, 2025, in San Francisco, CA. Tuesday’s session ‘Priorities in oncology R&D’ focused on the diverse directions of this sector of the industry amongst regulatory changes, existing and emerging innovations, and more.
The panel participants included: Dan Malarek, CEO of Foundation Medicine; Stephen Hahn, CEO of Harbinger Health; Maha Katabi, general partner at Sofinnova Investments; and Marjorie Green, svp, head of oncology and clinical development at Merck. John Carroll the founder & editor of Endpoints News was the moderator.
The discussion began with a dialogue about recent innovations in the space. Green commented on the recent...
Today's Sponsors
Today's Sponsor